RUA Life Sciences plc (RUA.L)

GBp 11.0

(0.0%)

Annual Income Statements

(In GBP)
Breakdown 2024 2023 2022 2021 2020 2019
Revenue 2.19 Million 2.17 Million 1.62 Million 1.52 Million 489 Thousand 463 Thousand
Cost of Revenue 475 Thousand 746 Thousand 580 Thousand 548 Thousand - -
Gross Profit 1.71 Million 1.43 Million 1.04 Million 980 Thousand 489 Thousand 463 Thousand
Operating Expenses 3.65 Million 3.82 Million 3.47 Million 2.77 Million 1.28 Million 1.1 Million
Selling, General and Administrative Expenses 2.47 Million 3.82 Million 3.47 Million 2.77 Million 1.28 Million 877 Thousand
Research and Development Expenses 887 Thousand 1.08 Million 928 Thousand 573 Thousand 34 Thousand 59 Thousand
Other Expenses 287 Thousand - - - - -
Cost and Expenses 4.12 Million 4.56 Million 4.05 Million 3.32 Million 1.48 Million 1.1 Million
Operating Income -1.93 Million -2.39 Million -2.42 Million -1.79 Million -991 Thousand -632 Thousand
Interest Expense 83 Thousand 16 Thousand 8000.00 43 Thousand - -
Income Tax Expense -580 Thousand -319 Thousand -293 Thousand -143 Thousand -81 Thousand -2141.00
Earnings before Tax -2.02 Million -2.32 Million -2.36 Million -1.59 Million -897 Thousand -609 Thousand
Net Income -1.44 Million -2 Million -2.06 Million -1.45 Million -816 Thousand -609 Thousand
Earnings Per Share Basic -0.04 -0.09 -0.09 -0.08 -0.06 -0.05
Earnings Per Share Diluted -0.04 -0.09 -0.09 -0.08 -0.06 -0.05
Weighted Average Shares Outstanding 33.56 Million 22.18 Million 22.18 Million 17.69 Million 14.76 Million 12.91 Million
Weighted Average Shares Outstanding (Diluted) 33.56 Million 22.18 Million 22.18 Million 17.69 Million 14.76 Million 12.91 Million
Gross Margin 0.78 0.66 0.64 0.64 1.00 1.00
EBIT Margin -0.72 -0.93 -1.30 -1.00 -1.63 -1.02
Profit Margin -0.66 -0.92 -1.27 -0.95 -1.67 -1.32
EBITDA -1.57 Million -1.94 Million -2.03 Million -1.27 Million -703 Thousand -391 Thousand
Earnings Before Tax Margin -0.88 -1.10 -1.49 -1.18 -2.03 -1.37

Income Statement Charts